Signaling Molecules in Posttransplantation Cancer
Authors:
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 39 (1) , 171-183
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health (CA222355, CA193675)
This publication has 23 references indexed in Scilit:
- Novel Approaches to Preventing Ischemia-Reperfusion Injury During Liver TransplantationTransplantation Proceedings, 2013
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40PLOS ONE, 2011
- The Kaposi's sarcoma‐associated herpesvirus G protein‐coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogeneJournal of Cellular Biochemistry, 2010
- Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer CellsCancer Research, 2009
- Viral Inhibitor of Apoptosis vFLIP/K13 Protects Endothelial Cells against Superoxide-Induced Cell DeathJournal of Virology, 2009
- Calcineurin Inhibitors Modulate CXCR3 Splice Variant Expression and Mediate Renal Cancer ProgressionJournal of the American Society of Nephrology, 2008
- Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation CancerCancer Research, 2008
- Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycinTransplant International, 2008
- Differential Effects of Immunosuppressive Drugs on T-Cell MotilityAmerican Journal of Transplantation, 2006